Has Nisha Desai, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,290 in general payments to Nisha Desai, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nisha Desai, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nisha Desai, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nisha Desai, MD

Dermatology · Skokie, ILNPI 1285895003

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Journey Medical Corporation at 35.2% of the total. Reporting peaked in 2019 at $601 and has fallen 83.1% since, to $102 in 2025. That places this record below the midpoint for dermatology clinicians in IL, where the typical reported total is $1,774.

$1,290in general payments, 2019–2025

Across 24 payments — averaging $53.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Journey Medical Corporation$454
AbbVie$269
Ortho Dermatologics, A Division Of Bausch Health US, LLC$225
Galderma Laboratories, L.p.$144
Sun Pharmaceutical Industries Inc.$139
Amgen$29
plus $31 from 2 others

$149,590in research payments, 2019–2025

Across 10 payments — averaging $14,959 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$150K

What the payments were for

Food & beverage$1,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Journey Medical Corporation	4	$454
AbbVie	11	$269
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$225
Galderma Laboratories, L.p.	1	$144
Sun Pharmaceutical Industries Inc.	2	$139
Amgen	2	$29
Cipher Pharmaceuticals US LLC	1	$16
Arcutis Biotherapeutics, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,290 in reported general payments places this provider in the 40th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois →

Medicare billing

Part B allowed, 2024

$150,270

Medicare patients

879

Services billed

3,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	147	$6,577
Ketoconazole	192	$2,953
Tretinoin	22	$2,678
Clindamycin Phosphate	64	$1,935
Metronidazole	21	$1,192
Mometasone Furoate	55	$1,110
Triamcinolone Acetonide	135	$961
Fluocinonide	33	$936
Ciclopirox	37	$847
Tacrolimus	12	$774
Betamethasone Dipropionate	20	$749
Doxycycline Monohydrate	23	$643
Mupirocin	50	$328
Spironolactone	13	$290
Hydrocortisone	30	$158

Paid to pharmacies, not to this prescriber.

Other dermatology in Skokie

Stephanie MehlisSkokie$145K
Benjamin GardenSkokie$22K
Ahmad AminNaperville$4.1M
Raj ChovatiyaChicago$3.6M
George LewittNorthbrook$3M
Peter LioChicago$2.4M
Elizabeth KiracofeChicago$1.6M
Lana SchmidtEffingham$1.3M
Melissa AbramsVernon Hills$600K
Carolyn JacobChicago$566K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →